ENANTA PHARMACEUTICALS, INC Assets, Fair Value Adjustment
ENANTA PHARMACEUTICALS, INC (ENTA) reported Assets, Fair Value Adjustment of $0 for the 12-month period ending 2021-09-30, per its 10-K filed 2021-11-24.
Discontinued › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:AssetsFairValueAdjustment · last filed 2021-11-24
- ENANTA PHARMACEUTICALS, INC assets, fair value adjustment for fiscal 2021 was $0.00.
- ENANTA PHARMACEUTICALS, INC assets, fair value adjustment for fiscal 2020 was $0.00.
- ENANTA PHARMACEUTICALS, INC assets, fair value adjustment for fiscal 2019 was $0.00.
- ENANTA PHARMACEUTICALS, INC assets, fair value adjustment for fiscal 2018 was $0.00.
| Period end | Assets, Fair Value Adjustment 12 month |
|---|---|
| 2021-09-30 | $0.00 10-K · filed 2021-11-24 |
| 2020-09-30 | $0.00 10-K · filed 2021-11-24 |
| 2019-09-30 | $0.00 10-K · filed 2021-11-24 |
| 2018-09-30 | $0.00 10-K · filed 2020-11-25 |
| 2017-09-30 | $0.00 10-K · filed 2019-11-27 |
| 2016-09-30 | $0.00 10-K · filed 2018-11-29 |
| 2015-09-30 | $0.00 10-K · filed 2017-12-11 |
| 2014-09-30 | $0.00 10-K · filed 2016-12-09 |
| 2013-09-30 | $0.00 10-K · filed 2015-12-11 |
| 2012-09-30 | $0.00 10-K · filed 2014-12-11 |
| 2011-09-30 | $0.00 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |